As such, we employed the osteosarcoma model used by Campbell et al. in order to further evaluate and characterize the response of NF-κB to doxorubicin, specifically focusing on determining whether the induced activation of NF-κB is pro- or anti-apoptotic. Here, NFKB1 is linked to osteosarcoma.